Annual Net Income
-$262.14 M
+$49.32 M+15.83%
December 31, 2023
Summary
- As of February 8, 2025, ARQT annual net profit is -$262.14 million, with the most recent change of +$49.32 million (+15.83%) on December 31, 2023.
- During the last 3 years, ARQT annual net income has fallen by -$126.46 million (-93.21%).
- ARQT annual net income is now -5165.97% below its all-time high of -$4.98 million, reached on December 31, 2017.
Performance
ARQT Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Income
-$41.54 M
+$10.79 M+20.63%
September 30, 2024
Summary
- As of February 8, 2025, ARQT quarterly net profit is -$41.54 million, with the most recent change of +$10.79 million (+20.63%) on September 30, 2024.
- Over the past year, ARQT quarterly net income has increased by +$3.23 million (+7.21%).
- ARQT quarterly net income is now -641.60% below its all-time high of -$5.60 million, reached on December 31, 2018.
Performance
ARQT Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Net Income
-$195.53 M
+$3.23 M+1.62%
September 30, 2024
Summary
- As of February 8, 2025, ARQT TTM net profit is -$195.53 million, with the most recent change of +$3.23 million (+1.62%) on September 30, 2024.
- Over the past year, ARQT TTM net income has increased by +$72.34 million (+27.01%).
- ARQT TTM net income is now -3391.07% below its all-time high of -$5.60 million, reached on December 31, 2018.
Performance
ARQT TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
ARQT Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +15.8% | +7.2% | +27.0% |
| 3 y3 years | -93.2% | +7.2% | +27.0% |
| 5 y5 years | -1261.4% | +7.2% | +27.0% |
ARQT Net Income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -27.0% | +15.8% | -17.4% | +61.4% | at high | +40.9% |
| 5 y | 5-year | -524.2% | +15.8% | -230.5% | +61.4% | -365.6% | +40.9% |
| alltime | all time | -5166.0% | +15.8% | -641.6% | +61.4% | -3391.1% | +40.9% |
Arcutis Biotherapeutics Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$41.54 M(-20.6%) | -$195.53 M(-1.6%) |
| Jun 2024 | - | -$52.33 M(+47.9%) | -$198.76 M(-8.6%) |
| Mar 2024 | - | -$35.38 M(-46.6%) | -$217.42 M(-17.1%) |
| Dec 2023 | -$262.14 M(-15.8%) | -$66.28 M(+48.1%) | -$262.14 M(-2.1%) |
| Sep 2023 | - | -$44.77 M(-36.9%) | -$267.88 M(-19.0%) |
| Jun 2023 | - | -$70.99 M(-11.4%) | -$330.82 M(+1.1%) |
| Mar 2023 | - | -$80.10 M(+11.2%) | -$327.23 M(+5.1%) |
| Dec 2022 | -$311.46 M(+50.9%) | -$72.02 M(-33.1%) | -$311.46 M(+0.2%) |
| Sep 2022 | - | -$107.71 M(+59.8%) | -$310.76 M(+19.5%) |
| Jun 2022 | - | -$67.41 M(+4.8%) | -$260.04 M(+10.8%) |
| Mar 2022 | - | -$64.32 M(-9.8%) | -$234.64 M(+13.7%) |
| Dec 2021 | -$206.36 M | -$71.33 M(+25.2%) | -$206.36 M(+22.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | -$56.98 M(+35.6%) | -$169.08 M(+12.5%) |
| Jun 2021 | - | -$42.01 M(+16.6%) | -$150.30 M(+4.6%) |
| Mar 2021 | - | -$36.04 M(+5.9%) | -$143.71 M(+5.9%) |
| Dec 2020 | -$135.68 M(+223.1%) | -$34.05 M(-10.9%) | -$135.68 M(+18.8%) |
| Sep 2020 | - | -$38.20 M(+7.9%) | -$114.20 M(+26.2%) |
| Jun 2020 | - | -$35.41 M(+26.4%) | -$90.47 M(+42.8%) |
| Mar 2020 | - | -$28.01 M(+122.9%) | -$63.35 M(+50.9%) |
| Dec 2019 | -$42.00 M(+118.1%) | -$12.57 M(-13.2%) | -$42.00 M(+19.9%) |
| Sep 2019 | - | -$14.48 M(+74.7%) | -$35.03 M(+70.5%) |
| Jun 2019 | - | -$8.29 M(+24.5%) | -$20.55 M(+67.6%) |
| Mar 2019 | - | -$6.66 M(+18.9%) | -$12.26 M(+118.9%) |
| Dec 2018 | -$19.25 M(+286.8%) | -$5.60 M | -$5.60 M |
| Dec 2017 | -$4.98 M | - | - |
FAQ
- What is Arcutis Biotherapeutics annual net profit?
- What is the all time high annual net income for Arcutis Biotherapeutics?
- What is Arcutis Biotherapeutics annual net income year-on-year change?
- What is Arcutis Biotherapeutics quarterly net profit?
- What is the all time high quarterly net income for Arcutis Biotherapeutics?
- What is Arcutis Biotherapeutics quarterly net income year-on-year change?
- What is Arcutis Biotherapeutics TTM net profit?
- What is the all time high TTM net income for Arcutis Biotherapeutics?
- What is Arcutis Biotherapeutics TTM net income year-on-year change?
What is Arcutis Biotherapeutics annual net profit?
The current annual net income of ARQT is -$262.14 M
What is the all time high annual net income for Arcutis Biotherapeutics?
Arcutis Biotherapeutics all-time high annual net profit is -$4.98 M
What is Arcutis Biotherapeutics annual net income year-on-year change?
Over the past year, ARQT annual net profit has changed by +$49.32 M (+15.83%)
What is Arcutis Biotherapeutics quarterly net profit?
The current quarterly net income of ARQT is -$41.54 M
What is the all time high quarterly net income for Arcutis Biotherapeutics?
Arcutis Biotherapeutics all-time high quarterly net profit is -$5.60 M
What is Arcutis Biotherapeutics quarterly net income year-on-year change?
Over the past year, ARQT quarterly net profit has changed by +$3.23 M (+7.21%)
What is Arcutis Biotherapeutics TTM net profit?
The current TTM net income of ARQT is -$195.53 M
What is the all time high TTM net income for Arcutis Biotherapeutics?
Arcutis Biotherapeutics all-time high TTM net profit is -$5.60 M
What is Arcutis Biotherapeutics TTM net income year-on-year change?
Over the past year, ARQT TTM net profit has changed by +$72.34 M (+27.01%)